A more recent study on melanoma survival ratios from the Human Protein Atlas and The Cancer Genome Atlas Genomic Data Commons (GDC) showed that while low ERβ expression was associated with shortened relapse-free survival (RFS), ERα and GPER were not [23]. This evidence concerns the gene ESR1 and melanoma.